{
    "DATE": " 9-MAR-1987 13:51:13.91",
    "TOPICS": [
        "acq"
    ],
    "PLACES": [
        "usa"
    ],
    "NEWID": "3277",
    "TEXT": {
        "TITLE": "MONTEDISON ACQUIRES ARCO RESEARCH UNIT",
        "DATELINE": "    MILAN, March 9 - ",
        "BODY": "Montedison SpA <MONI.MI> has acquired a 70\npct stake in <Plant Cell Research Institute - PCRI> of\nCalifornia from Atlantic Richfield Co <ARC.N> for \"several tens\nof millions of dollars,\" a senior Montedison executive said.\n    Renato Ugo, a member of Montedison's management committee,\ntold reporters that <Stanford Research Institute International>\nof Menlo Park, California, had acted as a partner in the\npurchase, itself acquiring a stake in PCRI of under 10 pct.\n    PCRI, based in Dublin, California has a biotechnology\nresearch laboratory.\n    Ugo said the price paid included outlays for the laboratory\ntechnology and staff.\n    He said other negotiations were under way with\nbiotechnology companies in the health care and diagnostics\nsectors through Montedison's health care subsidiary <Erbamont\nNV>, but gave no details.\n    \"We hope they will be concluded by the year end,\" he said.\n    Montedison currently invests around 30 billion lire a year\nin biotechnology research and expects to increase this figure\nto around 50 billion lire in the next few years.\n Reuter\n\u0003"
    },
    "ORGS": [
        "ec"
    ],
    "PEOPLE": [
        "reagan"
    ],
    "EXCHENGES": [
        "biffex"
    ]
}